What is Excelerate Energy's granted (in shares)?

Excelerate Energy (EE) reported granted (in shares) of 0 in Q1 2026.

What does granted (in shares) mean?

The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.

Excelerate Energy EE Granted (in shares)

Granted (in shares) at other companies

WingstopWING

0—

Oruka Therapeutics, Inc.ORKA

1.5M-12.6%

LivaNovaLIVN

957.7K+31.3%

The Hanover Insurance GroupTHG

148.1K+5.5%

GenpactG

0—

Ondas, Inc. ONDS

7.4M+45.6%

Other financials

Income statement

See full

Revenue$433.4M+37.6%

Operating income$82.0M+24.7%

Net income$12.3M-74.8%

EPS (diluted)$0.37-19.6%

Balance sheet

See full

Cash & equivalents$540.1M-12.8%

Total debt$1.3B+144%

Total assets$4.1B+41.7%

Cash flow

See full

Operating cash flow$60.0M-61.2%

CapEx$26.3M-40.4%

Free cash flow$33.7M-69.5%

Valuation

See full

Market cap$1.14B+21.1%

Enterprise value$1.85B+122%

P/E28.3×+15.9×

P/S0.8×-0.1×

Profitability

See full

Operating margin21%-3.4pp

Net margin3%-4.8pp

FCF margin16.4%—

Returns & leverage

See full

Current ratio2.6×-0.7×

Where this comes from

Reported directly by Excelerate Energy in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: Excelerate Energy’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Excelerate Energy's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Excelerate Energy's granted (in shares)?: Excelerate Energy (EE) reported granted (in shares) of 0 in Q1 2026.
What does granted (in shares) mean?: The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.